TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive Excitement building toward 2015 goal, NCI director says in FY07 bypass budget request. NCI seeks $5.8 billion. December 2, 2005
TCL Archive Increase In DCCR Grants May Not Be Possible Without Decreasing Quality, Committee Told July 28, 1978
